4//SEC Filing
CAUWENBERGH GEERT 4
Accession 0001209191-19-004688
CIK 0001533040other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 10:25 AM ET
Size
5.9 KB
Accession
0001209191-19-004688
Insider Transaction Report
Form 4
CAUWENBERGH GEERT
DirectorPresident & CEO
Transactions
- Award
Common stock, $0.0001 par value
2019-01-18$0.34/sh+23,729$8,096→ 285,428 total
Holdings
- 450(indirect: By Spouse)
Common stock, $0.0001 par value
Footnotes (1)
- [F1]As reported on the Current Report on Form 8-K filed on September 4, 2018 and December 21, 2018, the reporting person has elected to receive a portion of his compensation in stock in lieu of cash. Accordingly, on January 18, 2019, the reporting person received a total of 23,729 shares of common stock from the Company in lieu of $8,096.16 of cash compensation, which includes base salary, that was payable on such date.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001285648
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 10:25 AM ET
- Size
- 5.9 KB